PAP
DFTX

Persistent Asset Partners’s Definium Therapeutics DFTX Stock Holding History

Persistent Asset Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$300K Buy
+15,861
New +$269K 0.11% 155
2025
Q4 		– Sell
-24,282
Closed -$286K – 411
2025
Q3 		$286K Sell
24,282
-12,360
-34% -$115K 0.2% 113
2025
Q2 		$238K Buy
+36,642
New +$241K 0.18% 106

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Persistent Asset Partners's DFTX Position: Q1 2026 in Review

Persistent Asset Partners opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 15,861 shares worth $300K. The stake represents 0.11% of the portfolio and ranks #155 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in DFTX as recently as Q3 2025.

Persistent Asset Partners first reported a position in DFTX in Q2 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Persistent Asset Partners held 15,861 shares of Definium Therapeutics worth $300K as of Q1 2026.
  • Definium Therapeutics was a new Persistent Asset Partners position in Q1 2026.
  • Definium Therapeutics made up 0.11% of Persistent Asset Partners's portfolio in Q1 2026, its #155 holding.
  • Persistent Asset Partners first reported a position in Definium Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.